Ensysce Biosciences, Inc.

ENSC ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2019

Total Assets: $196.5M

Liabilities Breakdown FY2019

Total Liabilities: $17.5M